OKYO Pharma OKYO
NASDAQ OKYO
$1.54 +0.17 (+12.41%)
At close: Oct 21, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Cash from Operations (2025 - 2026)

Updated

OKYO Pharma's Cash from Operations was -$4.12 million in the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Cash from Operations (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Cash from Operations at OKYO Pharma came in at -$5.94 million.

  • In earlier years, Cash from Operations was -$1.81 million in the year ended Mar 31, 2025, -$9.49 million in the year ended Dec 31, 2024, -$7.7 million in the year ended Dec 31, 2023 and -$5.47 million in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 8.62 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.44 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.57 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 835.00 Mn
10 OKYO Pharma 1.03 Bn 999.20 Mn - -4.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.12 Mn
Dec 31, 2025 -282,535.00
API Access

OKYO Pharma Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=OKYO&period=max&api_key=YOUR_API_KEY